Home › Funds › Granahan Investment Management, LLC › STOK

Granahan Investment Management, LLC position in STOK

STOKE THERAPEUTICS INC · Health Care

Granahan Investment Management, LLC reported holding 461,608 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$15.1M, representing 0.54% of its reported portfolio and ranking #50 among its reported holdings. Granahan Investment Management, LLC has disclosed STOK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)461.61K sh
Reported value held$15.10M
Portfolio Weight0.54%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Granahan Investment Management, LLC's STOK position evolved

Granahan Investment Management, LLC first disclosed a stake in STOK in Q3 2023 at 851,201 shares (US$3.4M). The position peaked in Q2 2026 at 461,608 shares, worth US$15.1M. Across 12 filings, Granahan Investment Management, LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 461,608 shares valued at US$15.1M — an increase of 126,022 shares quarter over quarter.. Notable position changes include a 58% trim in Q1 2024 (shares were roughly flat over the following quarter), a 52% trim in Q3 2025 (shares rose 35% over the following quarter), a 75% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 851.20K $3.35M New
Q4 2023 1.14M $5.99M Add
Q1 2024 475.46K $6.42M Reduce
Q2 2024 598.40K $8.08M Add
Q3 2024 644.97K $7.93M Add
Q4 2024 567.69K $6.26M Reduce
Q1 2025 660.43K $4.39M Add
Q2 2025 532.41K $6.04M Reduce
Q3 2025 253.90K $5.97M Reduce
Q4 2025 191.40K $6.07M Reduce
Q1 2026 335.59K $10.93M Add
Q2 2026 461.61K $15.10M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STOK and 13F data

STOK (STOKE THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STOK

All STOK fund holders →

FAQ

How long has Granahan Investment Management, LLC held STOK?

Granahan Investment Management, LLC has disclosed STOK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Granahan Investment Management, LLC's current position in STOK?

As of Q2 2026, Granahan Investment Management, LLC holds 461.61K shares of STOK (STOKE THERAPEUTICS INC), valued at $15.10M, representing 0.54% of its reported portfolio and ranking #50.

Has Granahan Investment Management, LLC been buying or selling STOK?

In the latest 13F filing (Q2 2026), Granahan Investment Management, LLC increased its position in STOK. The position peaked in Q2 2026 at 461.61K shares.

Which other funds hold STOK?

Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.